• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Immune cell infiltration as a prognostic factor in endometrial cancer: a meta-analysis.免疫细胞浸润作为子宫内膜癌的一个预后因素:一项荟萃分析。
Am J Cancer Res. 2025 Mar 15;15(3):1335-1345. doi: 10.62347/BXZM8857. eCollection 2025.
2
The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis.胰腺癌中肿瘤浸润淋巴细胞的预后价值:系统评价和荟萃分析。
Eur J Cancer. 2020 Jun;132:71-84. doi: 10.1016/j.ejca.2020.03.013. Epub 2020 Apr 22.
3
Development and validation of a prognostic prediction model for endometrial cancer based on CD8+ T cell infiltration-related genes.基于CD8 + T细胞浸润相关基因的子宫内膜癌预后预测模型的建立与验证
Medicine (Baltimore). 2024 Dec 6;103(49):e40820. doi: 10.1097/MD.0000000000040820.
4
Intratumoral CD8+ Lymphocyte Infiltration as a Prognostic Factor and Its Relationship With Cyclooxygenase 2 Expression and Microsatellite Instability in Endometrial Cancer.肿瘤内CD8 +淋巴细胞浸润作为子宫内膜癌的预后因素及其与环氧合酶2表达和微卫星不稳定性的关系
Int J Gynecol Cancer. 2015 Sep;25(7):1165-72. doi: 10.1097/IGC.0000000000000482.
5
Biomarkers of tumor-reactive CD4 and CD8 TILs associate with improved prognosis in endometrial cancer.肿瘤反应性 CD4 和 CD8 TILs 的生物标志物与子宫内膜癌的改善预后相关。
J Immunother Cancer. 2022 Dec;10(12). doi: 10.1136/jitc-2022-005443.
6
Tissue-resident memory T-cell expressions and their prognostic role in head and neck squamous cell carcinoma: a systematic review and meta-analysis.组织驻留记忆T细胞表达及其在头颈部鳞状细胞癌中的预后作用:一项系统评价和荟萃分析
BMC Cancer. 2025 Feb 26;25(1):356. doi: 10.1186/s12885-025-13764-2.
7
The NSCLC immunotherapy response predicted by tumor-infiltrating T cells via a non-invasive radiomic approach.通过一种非侵入性的放射组学方法预测 NSCLC 免疫治疗反应的肿瘤浸润 T 细胞。
Front Immunol. 2024 Sep 9;15:1379812. doi: 10.3389/fimmu.2024.1379812. eCollection 2024.
8
The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients.低级别、早期子宫内膜癌患者肿瘤免疫微环境与临床结局的相关性。
J Pathol. 2022 Dec;258(4):426-436. doi: 10.1002/path.6012. Epub 2022 Oct 25.
9
Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer.子宫内膜癌中T细胞克隆性及免疫相关基因表达水平的临床意义
Oncol Rep. 2017 May;37(5):2603-2610. doi: 10.3892/or.2017.5536. Epub 2017 Mar 29.
10
Immune checkpoint proteins (PD-L1 and CTLA-4) in endometrial carcinoma: prognostic role and correlation with CD4/CD8 tumor infiltrating lymphocytes (TILs) ratio.免疫检查点蛋白(PD-L1 和 CTLA-4)在子宫内膜癌中的作用:预后作用及其与 CD4/CD8 肿瘤浸润淋巴细胞(TILs)比值的相关性。
J Immunoassay Immunochem. 2022 Mar 4;43(2):192-212. doi: 10.1080/15321819.2021.1981377. Epub 2021 Oct 26.

本文引用的文献

1
Mutation in Endometrial Endometrioid Carcinoma Is Associated with Poor Clinical Outcomes and High Tumor Mutation Burden.子宫内膜样癌的基因突变与不良临床结局和高肿瘤突变负荷相关。
Cancer Invest. 2024 Apr;42(4):297-308. doi: 10.1080/07357907.2024.2334249. Epub 2024 Apr 26.
2
Ferroptosis, Metabolic Rewiring, and Endometrial Cancer.铁死亡、代谢重编程与子宫内膜癌
Int J Mol Sci. 2023 Dec 20;25(1):75. doi: 10.3390/ijms25010075.
3
Abnormal preoperative haematological parameters in Endometrial cancer; reflecting tumour aggressiveness or reduced response to radiotherapy?子宫内膜癌患者术前血液学参数异常;反映肿瘤侵袭性还是对放疗反应降低?
J Obstet Gynaecol. 2024 Dec;44(1):2294332. doi: 10.1080/01443615.2023.2294332. Epub 2024 Jan 7.
4
Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma.肿瘤免疫微环境和NRF2与肺鳞状细胞癌中PD-1阻断联合化疗的临床疗效相关。
Cell Rep Med. 2023 Dec 19;4(12):101302. doi: 10.1016/j.xcrm.2023.101302. Epub 2023 Dec 4.
5
Targeting regulatory T cells by E7777 enhances CD8 T-cell-mediated anti-tumor activity and extends survival benefit of anti-PD-1 in solid tumor models.E7777 通过靶向调节性 T 细胞增强 CD8 T 细胞介导的抗肿瘤活性,并延长抗 PD-1 在实体瘤模型中的生存获益。
Front Immunol. 2023 Oct 27;14:1268979. doi: 10.3389/fimmu.2023.1268979. eCollection 2023.
6
Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer: NeoPACT Phase 2 Clinical Trial.新辅助帕博利珠单抗联合卡铂加多西他赛治疗三阴性乳腺癌的临床和生物标志物研究:NeoPACT Ⅱ期临床试验。
JAMA Oncol. 2024 Feb 1;10(2):227-235. doi: 10.1001/jamaoncol.2023.5033.
7
Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma.全面分析乳头状肾细胞癌的免疫肿瘤微环境。
J Immunother Cancer. 2023 Nov;11(11). doi: 10.1136/jitc-2023-006885.
8
FIGO 2023 endometrial cancer staging: too much, too soon?FIGO 2023 子宫内膜癌分期:太多、太快?
Int J Gynecol Cancer. 2024 Jan 5;34(1):138-143. doi: 10.1136/ijgc-2023-004981.
9
Clinical trial links oncolytic immunoactivation to survival in glioblastoma.临床试验将溶瘤免疫激活与胶质母细胞瘤的生存联系起来。
Nature. 2023 Nov;623(7985):157-166. doi: 10.1038/s41586-023-06623-2. Epub 2023 Oct 18.
10
Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase Ib Trial.综合单细胞免疫分析定义了 Ib 期临床试验中溶瘤病毒治疗后患者多发性骨髓瘤的微环境。
Clin Cancer Res. 2023 Dec 15;29(24):5087-5103. doi: 10.1158/1078-0432.CCR-23-0229.

免疫细胞浸润作为子宫内膜癌的一个预后因素:一项荟萃分析。

Immune cell infiltration as a prognostic factor in endometrial cancer: a meta-analysis.

作者信息

Lin Yibin, Lin Qiaoming, Guan Qi, Chen Danru, Zhou Yan, Li Sang

机构信息

Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital Fuzhou 350014, Fujian, PR China.

出版信息

Am J Cancer Res. 2025 Mar 15;15(3):1335-1345. doi: 10.62347/BXZM8857. eCollection 2025.

DOI:10.62347/BXZM8857
PMID:40226477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11982738/
Abstract

The immune system's role in cancer development and progression is receiving increasing attention. Endometrial cancer, common gynecological malignancy, has exhibited promising responses to immunotherapies. This study aims to assess the prognostic significance of various immune cell subsets in endometrial cancer, focusing on potential novel biomarkers and therapeutic targets. A systematic literature review and meta-analysis were conducted. Eleven eligible studies, comprising 2,319 patients with endometrial cancer, were included. The primary outcome was the association between levels of immune cell types, particularly CD8+ T cells, and overall prognosis. The meta-analysis found that high levels of tumor-infiltrating lymphocytes (TILs), particularly CD8+ T cells, were significantly associated with better overall prognosis in endometrial cancer patients. These findings suggest that the tumor immune microenvironment plays a crucial role in endometrial cancer prognosis. This meta-analysis indicates that higher levels of CD8+ T cells in the tumor microenvironment are linked to improved prognosis in endometrial cancer, underscoring the immune system's potential in prognostication and therapy.

摘要

免疫系统在癌症发生和发展中的作用正受到越来越多的关注。子宫内膜癌作为常见的妇科恶性肿瘤,已显示出对免疫疗法有良好反应。本研究旨在评估各种免疫细胞亚群在子宫内膜癌中的预后意义,重点关注潜在的新型生物标志物和治疗靶点。我们进行了一项系统的文献综述和荟萃分析。纳入了11项符合条件的研究,共2319例子宫内膜癌患者。主要结局是免疫细胞类型水平,特别是CD8 + T细胞水平与总体预后之间的关联。荟萃分析发现,肿瘤浸润淋巴细胞(TILs)水平较高,尤其是CD8 + T细胞,与子宫内膜癌患者更好的总体预后显著相关。这些发现表明,肿瘤免疫微环境在子宫内膜癌预后中起着关键作用。该荟萃分析表明,肿瘤微环境中较高水平的CD8 + T细胞与子宫内膜癌预后改善相关,强调了免疫系统在预后评估和治疗中的潜力。